## Abstract The detection of the association between nephrogenic systemic fibrosis (NSF), a rare but potentially lifeβthreatening disease only encountered in patients with severely impaired renal function, and the previous administration of some Gdβchelates has cast a shadow on the administration o
Clinical Images: Scurvy in the modern era
β Scribed by Brian DelVecchio; Sorina Dancea
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 65 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
β¦ Synopsis
Diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) mapping can help to differentiate an ischemic lesion, which appears hyperintense on DWI and hypointense on ADC maps, from a lesion due to PRES, which does not appear hypointense on ADC maps (5). The distinction between PRES and central nervous system vasculitis can easily be made, since vasculitis lacks the typical MRI findings of PRES, and the diagnosis relies on corroborative data from cerebrospinal fluid analysis, angiography, and perfusion studies, with brain biopsy being the gold standard.
When we initially presented our case, we decided against showing the subsequent MRI, since PRES MRI at presentation is characteristic and particularly useful in guiding diagnosis and treatment. We concur that reversibility is essential to the diagnosis of PRES and that was convincingly demonstrated in our patient during the followup MRI series, performed 1 year after the initial diagnosis. We observed a dramatic resolution of the characteristic lesions, aside from a small area of watershed infarction (Figures 1A andB).
π SIMILAR VOLUMES
The assessment of gene function, which follows the completion of human genome sequencing, may be performed using the tools of the genome program. These tools represent high-throughput methods evaluating changes in the expression of many or all genes of an organism at the same time in order to invest
Medicine is undergoing a quiet revolution. Molecular genetics is transforming clinical science and practice; the development of the Human Genome Project allows new methods of disease identification and of predicting disease patterns for individual patients. Knowledge of the human genome will deepen